Want to see NTRB full AI Analyst Report?

Nutriband (NTRB) Price & Analysis

142 Followers

NTRB Stock Chart & Stats

$4.42

-$0.10(-2.25%)

At close: Jan 08 4:00 PM EST

$4.42

-$0.10(-2.25%)

Day’s Range― - ―

52-Week Range$2.90 - $11.68

Previous CloseN/A

Volume13.23K

Average Volume (3M)31.62K

Market Cap

$37.56M

Enterprise Value$33.42M

Total Cash (Recent Filing)$4.01M

Total Debt (Recent Filing)$232.71K

Price to Earnings (P/E)―

Beta1.40

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding12,155,983

10 Day Avg. Volume33,995

30 Day Avg. Volume31,617

Financial Highlights & Ratios

PEG Ratio-0.01

Price to Book (P/B)8.35

Price to Sales (P/S)27.38

P/FCF Ratio-10.86

Enterprise Value/Market Cap0.89

Enterprise Value/Revenue18.54

Enterprise Value/Gross Profit65.39

Enterprise Value/Ebitda-4.24

Forecast

1Y Price Target

$15.00

Price Target Upside239.37% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Market GrowthThe additional safety from the abuse-deterrent technology could potentially grow the market and drive upward revisions to estimates.

PartnershipsNutriband has a partnership with Kindeva Drug Delivery, formerly part of 3M, to add the AVERSA technology to Kindeva’s transdermal fentanyl patch.

Product DevelopmentThe AVERSA Fentanyl patch could prevent abuse and accidental misuse of fentanyl transdermal patches.

Bears Say

Development CostsNutriband and its partner, Kindeva, have amended their development and commercialization agreement covering AVERSA Fentanyl, the abuse-deterrent transdermal fentanyl patch in development.

Nutriband News

Nutriband Secures New Three-Year $5M Credit Facility

Nutriband ( ($NTRB) ) just unveiled an update. On June 1, 2026, Nutriband entered into an amended three-year...

11d ago

NTRB

Nutriband Advances Lead Abuse-Deterrent Fentanyl Patch Branding

Nutriband ( ($NTRB) ) just unveiled an announcement. On March 30, 2026, Nutriband Inc. announced it has chosen...

3M ago

NTRB

Nutriband’s Kinesiology Tapes approved for distribution and sale in Costa Rica

Nutriband (NTRB) announced that The Costa Rica Ministry of Health has approved the Company’s line of Kinesiology Tapes...

4M ago

NTRB

Nutriband signs exclusive distribution agreement with Innomedica

Nutriband (NTRB) signed an exclusive distribution agreement with Costa Rica Based Innomedica for AVERSA Fentanyl upon approval and...

5M ago

NTRB

Nutriband Cancels Planned Sale of Pocono Pharmaceuticals

The latest update is out from Nutriband ( ($NTRB) ). On February 13, 2026, Nutriband’s Board of Directors...

5M ago

NTRB

Nutriband shareholders approve proposals and expand board leadership

Nutriband ( ($NTRB) ) has provided an update. Nutriband held its 2026 Annual Meeting of Stockholders on January...

5M ago

NTRB

Nutriband provides summary of annual shareholder meeting

Nutriband (NTRB) has provided an update to shareholders on the key milestones and discussions from this years Annual...

5M ago

NTRB

Nutriband says ‘committed’ to shareholder value as ‘number one focus’

Nutriband (NTRB) announced that CEO Gareth Sheridan has published a letter to shareholders providing insights on achievements and...

6M ago

NTRB

Nutriband Divests Pocono Stake to Fund AVERSA Fentanyl

An announcement from Nutriband ( ($NTRB) ) is now available. On December 29, 2025, Nutriband Inc. announced that...

6M ago

NTRB

Nutriband to sell majority stake of Pocono Pharmaceutical for $5M

Nutriband (NTRB) signed an agreement to sell a 90% interest in its subsidiary Pocono Pharmaceutical for $5M to...

6M ago

NTRB

Trump Trade: Trump Media to merge with TAE Technologies

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by...

7M ago

DJT

SPY

Nutriband signs LOI with Qvanta Group of companies

Nutriband (NTRB) announced the signing of a non-binding Letter of Intent with the Qvanta Group of Companies. The...

7M ago

NTRB

Nutriband provides response to Trump’s Executive Order related to fentanyl

Nutriband (NTRB) provides the following response to the Trump Administration’s Executive Order designating illicit fentanyl and its core...

7M ago

NTRB

Nutriband Advances with FDA on Fentanyl Patch

Nutriband ( ($NTRB) ) has shared an update. Nutriband Inc. announced the successful completion of a meeting with...

8M ago

NTRB

NTRB FAQ

What was Nutriband Inc’s price range in the past 12 months?

Nutriband Inc lowest stock price was $2.90 and its highest was $11.68 in the past 12 months.

What is Nutriband Inc’s market cap?

Nutriband Inc’s market cap is $37.56M.

When is Nutriband Inc’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Nutriband Inc’s earnings last quarter?

Currently, no data Available

Is Nutriband Inc overvalued?

According to Wall Street analysts Nutriband Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Nutriband Inc pay dividends?

Nutriband Inc does not currently pay dividends.

What is Nutriband Inc’s EPS estimate?

Nutriband Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Nutriband Inc have?

Nutriband Inc has 12,155,983 shares outstanding.

What happened to Nutriband Inc’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Nutriband Inc?

Currently, no hedge funds are holding shares in NTRB

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Nutriband Stock Smart Score

Underperform

Analyst Consensus

Moderate Buy

Average Price Target:
$15.00 (239.37% Upside)

Technicals

Fundamentals

Return on Equity

-112.60%

Trailing 12-Months

Asset Growth

12.03%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Nutriband Inc

Nutriband Inc. specializes in developing a diverse range of pharmaceutical products delivered via transdermal patches. The company's most advanced program centers on AVERSA fentanyl, an innovative fentanyl transdermal system engineered to prevent abuse. This extended-release patch provides healthcare professionals and patients with a continuous opioid therapy solution for the ongoing management of chronic pain. Its development pipeline also includes other treatments, such as AVERSA buprenorphine and AVERSA methylphenidate. Additionally, Nutriband is working on exenatide for individuals with type 2 diabetes and follicle stimulating hormone as a treatment for infertility. The company also holds a licensing agreement with Rambam Med-Tech Ltd. to further the development of RAMBAM Closed System Transfer Devices. Nutriband Inc. was founded in 2016 and its main offices are located in Orlando, Florida.

Nutriband (NTRB) Earnings & Revenues

Historic Earnings Reports

NTRB Stock 12 Month Forecast

Average Price Target

$15.00

▲(239.37% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"$2","9":"$9","16":"$16","5.5":"$5.5","12.5":"$12.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":15,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$15.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$15.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$15.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2,5.5,9,12.5,16],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.09,4.006153846153846,4.922307692307692,5.838461538461539,6.754615384615384,7.670769230769231,8.586923076923078,9.503076923076923,10.419230769230769,11.335384615384616,12.251538461538463,13.167692307692308,14.083846153846155,{"y":15,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.09,4.006153846153846,4.922307692307692,5.838461538461539,6.754615384615384,7.670769230769231,8.586923076923078,9.503076923076923,10.419230769230769,11.335384615384616,12.251538461538463,13.167692307692308,14.083846153846155,{"y":15,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.09,4.006153846153846,4.922307692307692,5.838461538461539,6.754615384615384,7.670769230769231,8.586923076923078,9.503076923076923,10.419230769230769,11.335384615384616,12.251538461538463,13.167692307692308,14.083846153846155,{"y":15,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":8.02,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.39,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.17,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.27,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.73,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.94,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.54,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":4.69,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":4.31,"date":1772323200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":3.6,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.86,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.55,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.09,"date":1782864000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >